Matthew Scholz
About Matthew Scholz
Matthew Scholz is a seasoned entrepreneur and technology executive based in the Greater Seattle Area. He co-founded several companies, including Immusoft Corporation, Aegis Life, Inc., Sigma Genetics, Inc., Oisin Biotechnologies, and OncoSenX, and has held various leadership roles in these organizations since 2009.
Work at Immusoft Corporation
Matthew Scholz has been involved with Immusoft Corporation since its inception. He served as Founder and Chief Executive Officer from 2009 to 2018, overseeing the company's strategic direction and operations for nine years. In 2018, he transitioned to the role of Founder and Board of Directors, contributing to the company's governance and long-term vision. His tenure at Immusoft has spanned a total of 15 years, highlighting his commitment to the organization and its mission.
Current Roles and Responsibilities
Currently, Matthew Scholz holds multiple positions in various organizations. He is the Co-Founder and Chief Technical Officer at Aegis Life, Inc., a role he has maintained since 2020. Additionally, he serves as Co-Founder and Board of Directors member at Sigma Genetics, Inc. since 2016, and as Chief Executive Officer at Oisin Biotechnologies since 2018. He also holds the position of Chief Executive Officer at OncoSenX since 2018. His diverse roles reflect his extensive expertise in biotechnology and leadership.
Education and Expertise
Matthew Scholz studied Computer Science at the University of Washington, where he earned a Bachelor of Science degree from 1998 to 2002. He further enhanced his entrepreneurial skills by participating in Y Combinator in 2017 for 11 months. His educational background, combined with his extensive experience in the biotechnology sector, equips him with a strong foundation in both technical and business aspects of the industry.
Background in Biotechnology
Matthew Scholz has a significant background in the biotechnology field, having co-founded multiple companies focused on innovative solutions. His experience spans various roles, including leadership positions at Immusoft Corporation, Aegis Life, Inc., Oisin Biotechnologies, and OncoSenX. His work primarily involves advancing biotechnological applications and contributing to the development of new therapies, showcasing his dedication to improving healthcare outcomes.
Leadership Experience
Matthew Scholz has demonstrated substantial leadership experience throughout his career. As a founder and executive in several biotechnology companies, he has played a pivotal role in shaping their strategic direction and operational frameworks. His leadership roles at Immusoft Corporation, Aegis Life, Inc., Oisin Biotechnologies, and OncoSenX reflect his ability to guide organizations through various stages of growth and development in the competitive biotech landscape.